Percentage of cancer in prostate biopsies as prognostic factor for staging and postoperative biochemical failure after radical prostatectomy

Urologia Internationalis

Volumn 78, Issue 4, 2007, Pages 328-333

  Villamón Fort, Rafael ^a   Martínez Jabaloyas, José M ^a   Soriano Sarriá, Pilar ^a   Ramos Soler, David ^a   Pastor Hernández, Francisco ^a   Gil Salom, Manuel ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Needle biopsy; Prognosis; Prostate cancer; Prostatectomy; Tumor staging

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACCURACY; ADULT; AGED; ARTICLE; BIOCHEMISTRY; CANCER GROWTH; CANCER PATIENT; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER TISSUE; CONTROLLED STUDY; GLEASON SCORE; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEEDLE BIOPSY; PATHOLOGY; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RECURRENCE RISK; RISK ASSESSMENT; SURGICAL PATIENT; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR BIOPSY; UNIVARIATE ANALYSIS;

AGED; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 34248137982     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000100837     Document Type: Article

References (24)

1. Partin AW, Yoo J, Carter HB, Pearson JD, Chan DW, Epstein JI, Walsh PC: The use of prostate specific antigen, clinic stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 1993;150:110-114.
2. Partin AW, Walsh PC: The use of prostate specific antigen, clinic stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 1994;152:172-173.
3. Partin AW, Kattan MW, Subong EN, Walsh PC, Wojno KJ, Oesterling JE, Scardino PT, Pearson JD: Combination of prostate-specific antigen, clinical stage and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional study. JAMA 1997;277:1445-1451.
4. Gilliland FD, Hoffman RM, Hamilton A, Albertsen P, Eley JW, Harlan L, Stanford JL, Hunt WC, Potosky A, Stephenson RA: Predicting extracapsular extension of prostate cancer in men treated with radical prostatectomy: results from the population based prostate cancer outcomes study. J Urol 1999;162:1341-1345.
5. Huland H, Hammerer P, Henke RP, Huland E: Preoperative prediction of tumor heterogeneity and recurrence after radical prostatectomy for localized prostatic carcinoma with digital rectal examination, prostate specific antigen and the results of 6 systematic biopsies. J Urol 1996;155:1344-1347.
6. Thickman D, Speers WC, Philpott PJ, Shapiro H: Effect of the number of core biopsies of the prostate on predicting Gleason score of prostate cancer. J Urol 1996;156:110-113.
7. Goto Y, Ohori M, Arakawa A, Kattan M, Wheeler T, Scardino P: Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies. J Urol 1996;156:1059-1063.
8. Goto Y, Ohori M, Scardino PT: Use of systematic biopsy results to predict pathologic stage in patients with clinically localized prostate cancer: a preliminary report. Int J Urol 1998;5:337-342.
9. Borirakchanyavat S, Bhargava V, Shinohara K, Toke A, Carroll PR, Presti JC Jr: Systematic sextant biopsies in the prediction of extracapsular extension at radical prostatectomy. Urology 1997;50:373-378.
10. Ravery V, Chastang C, Toublanc M, Boccon-Gibod L, Delmas V, Boccon-Gibod L: Percentage of cancer on biopsy cores accurately predicts extracapsular extension and biochemical relapse after radical prostatectomy for T1-T2 prostate cancer. Eur Urol 2000;37:449-455.
11. Grossfeld GD, Latini DM, Lubeck DP, Broering JM, Li YP, Metha SS, Carroll PR: Predicting disease recurrence in intermediate and high-risk patients undergoing radical prostatectomy using percent positive biopsies: results from CaPSURE. Urology 2002;59:560-565.
12. Grossfeld GD, Latini DM, Lubeck DP, Mehta SS, Carroll PR: Predicting recurrence after radical prostatectomy for patients with high risk prostate cancer. J Urol 2003;169:157-163.
13. Freedland SJ, Csathy GS, Dorey F, Aronson WJ: Clinical utility of percent prostate needle biopsy tissue with cancer cutpoints to risk stratify patients before radical prostatectomy. Urology 2002;60:84-88.
14. Ravery V, Boccon-Gibod LA, Dauge-Geffroy MC, Billebaud T, Delmas V, Meulemans A, Meulemans A, Toublanc M, Boccon-Gibod L: Systematic Biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy. Urology 1994;44:371-376.
15. Wills ML, Sauvageot J, Partin AW, Gurganus R, Epstein JI: Ability of sextant biopsies to predict radical prostatectomy stage. Urology 1998;51:759-764.
16. Epstein JI, Chan DW, Sokoll LJ, Walsh PC, Cox JL, Rittenhouse H, Wolfert R, Carter HB: Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen and needle biopsy findings. J Urol 1998;160:2407-2411.
17. Egawa S, Suyama K, Matsumoto K, Satoh T, Uchida T, Kuwao S, Koshiba K: Improved predictability of extracapsular extension and seminal vesicle involvement based on clinical and biopsy findings in prostate cancer in Japanese men. Urology 1998;52:433-440.
18. Ogawa O, Egawa S, Arai Y, Tobisu K, Yoshida O, Kato T: Preoperative predictors for organ-confined disease in Japanese patients with stage T1c prostate cancer. Int J Urol 1998;5:454-458.
19. Sebo TJ, Bock BJ, Cheville JC, Lohse C, Wollan P, Zincke H: The percent of cores positive for cancer in prostate needle biopsy specimens in strongly predictive of tumor stage and volume at radical prostatectomy. J Urol 2000;163:174-178.
20. Freedland SJ, Csathy GS, Dorey F, Aronson WJ: Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score. J Urol 2002;167:516-520.
21. Bostwick D, Qian J, Bergstralh E, Dundore P, Dugan J, Myers R, Oesterling JE: Prediction of capsular perforation and seminal vesicle invasion in prostate cancer. J Urol 1996;155:1361-1367.
22. Peters-Gee JM: An update on the role of ploidy in prostate carcinoma. Henry Ford Hosp Med J 1992;40:99-102.
23. Ross JS, Figge H, Bui HX, del Rosario AD, Jennings TA, Rifkin MD, Fisher HA: Prediction of pathologic stage and postprostatectomy disease recurrence by DNA ploidy analysis of initial needle biopsy specimens of prostate cancer. Cancer 1994;74:2811.
24. Bastacky SI, Walsh PC, Epstein JI: Relationship between perineural tumor invasion on needle biopsy and radical prostatectomy capsular penetration in clinical stage B adenocarcinoma of the prostate. Am J Surg Pathol 1993;17:336-341.